000 01111 a2200289 4500
005 20250516110019.0
264 0 _c20130213
008 201302s 0 0 eng d
022 _a1569-8041
024 7 _a10.1093/annonc/mds264
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEggermont, A M M
245 0 0 _aCan immuno-oncology offer a truly pan-tumour approach to therapy?
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cSep 2012
300 _aviii53-7 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aCancer Vaccines
_ximmunology
650 0 4 _aCombined Modality Therapy
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aMale
650 0 4 _aMelanoma
_ximmunology
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aProstatic Neoplasms
_ximmunology
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 23 Suppl 8
_gp. viii53-7
856 4 0 _uhttps://doi.org/10.1093/annonc/mds264
_zAvailable from publisher's website
999 _c22048999
_d22048999